학술논문

Pembrolizumab With R-CHOP in Previously Untreated DLBCL: Sustained, High Efficacy, and Safety With Long-Term Follow-Up
Document Type
Article
Source
In Clinical Lymphoma, Myeloma and Leukemia February 2024 24(2):e33-e39
Subject
Language
ISSN
2152-2650